European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
Alan R Smyth1, Scott C Bell2, Snezana Bojcin3
1Division of Child Health, Obstetrics & Gynaecology (COG), School of Medicine, University of Nottingham, UK.
Insights
Specialized care has significantly improved survival for cystic fibrosis (CF) patients. Newborn screening enables early intervention, enhancing quality of life and life expectancy for individuals with CF.
Area of Science:
- Medical Research
- Pulmonology
- Genetics
Background:
- Specialized care has dramatically improved survival rates in cystic fibrosis (CF) over the past four decades.
- Newborn screening for CF is increasingly implemented in Europe, identifying patients with minimal lung disease at diagnosis.
- This allows for a focus on maintaining excellent quality of life and extending life expectancy.
Purpose of the Study:
- To update and build upon the 2005 landmark document setting standards for CF care across Europe.
- To provide a comprehensive overview of best practices in key aspects of CF management.
- To guide clinical teams in both developing and established CF centers.
Main Methods:
- Development of a best practice document based on existing European Consensus Statements, Guidelines, and Position Papers.
- Review and synthesis of current standards in screening, diagnosis, and treatment.
- Inclusion of recommendations for nutrition, complication management, transplant/end-of-life care, and psychological support.
Main Results:
- The document outlines expected standards for comprehensive CF care.
- It emphasizes the potential for excellent quality of life and extended life expectancy with early diagnosis and intervention.
- References to up-to-date European guidelines are provided for detailed clinical management.
Conclusions:
- This best practice document serves as a vital resource for optimizing CF care throughout Europe.
- It aims to ensure high-quality, standardized care for all individuals with cystic fibrosis.
- The guidelines support clinical teams in delivering optimal outcomes for patients, from diagnosis through end-of-life care.
Abstract:
Specialised CF care has led to a dramatic improvement in survival in CF: in the last four decades, well above what was seen in the general population over the same period. With the implementation of newborn screening in many European countries, centres are increasingly caring for a cohort of patients who have minimal lung disease at diagnosis and therefore have the potential to enjoy an excellent quality of life and an even greater life expectancy than was seen previously. To allow high quality care to be delivered throughout Europe, a landmark document was published in 2005 that sets standards of care. Our current document builds on this work, setting standards for best practice in key aspects of CF care. The objective of our document is to give a broad overview of the standards expected for screening, diagnosis, pre-emptive treatment of lung disease, nutrition, complications, transplant/end of life care and psychological support. For comprehensive details of clinical care of CF, references to the most up to date European Consensus Statements, Guidelines or Position Papers are provided in Table 1. We hope that this best practice document will be useful to clinical teams both in countries where CF care is developing and those with established CF centres.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Standards of Care II
Standards of Care I
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
